TherapeuticsMD | TXMD - PE Price to Earnings


TherapeuticsMD reported 0.75 in PE Price to Earnings for its fiscal quarter ending in March of 2023.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Grifols 11.2 1.08 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pfizer 14.48 5.18 Dec/2025
TherapeuticsMD 0.75 3.3 Mar/2023